Circulation by Ford, Earl S. et al.
Ideal Cardiovascular Health and Mortality From All Causes and 
Diseases of the Circulatory System Among Adults in the United 
States
Earl S. Ford, MD, MPH, Kurt J. Greenlund, PhD, and Yuling Hong, MD, PhD
Divisions of Adult and Community Health (E.S.F., K.J.G.) and Heart Disease and Stroke 
Prevention (Y.H.), National Center for Chronic Disease Prevention and Health Promotion, 
Centers for Disease Control and Prevention, Atlanta, GA
Abstract
Background—Recently, the American Heart Association developed a set of 7 ideal health 
metrics that will be used to measure progress toward their 2020 goals for cardiovascular health. 
The objective of the present study was to examine how well these metrics predicted mortality from 
all causes and diseases of the circulatory system in a national sample of adults in the United 
States.
Methods and Results—We used data from 7622 adults ≥20 years of age who participated in 
the National Health and Nutrition Examination Survey from 1999 to 2002 and whose mortality 
through 2006 was determined via linkage to the National Death Index. For the dietary and 
glycemic metrics, we used alternative measures. During a median follow-up of 5.8 years, 532 
deaths (186 deaths resulting from diseases of the circulatory system) occurred. About 1.5% of 
participants met none of the 7 ideal cardiovascular health metrics, and 1.1% of participants met all 
7 metrics. The number of ideal metrics was significantly and inversely related to mortality from all 
causes and diseases of the circulatory system. Compared with participants who met none of the 
ideal metrics, those meeting ≥5 metrics had a reduction of 78% (adjusted hazard ratio, 0.22; 95% 
confidence interval, 0.10–0.50) in the risk for all-cause mortality and 88% (adjusted hazard ratio, 
0.12; 95% confidence interval, 0.03–0.57) in the risk for mortality from diseases of the circulatory 
system.
Conclusion—The number of ideal cardiovascular health metrics is a strong predictor of 
mortality from all causes and diseases of the circulatory system.
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Despite an impressive decline in the mortality rate from coronary heart disease and stroke 
since the 1960s, preliminary estimates for 2010 show that 595 444 people died of diseases of 
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the heart, which remains the leading cause of death in the United States, and 129 180 died of 
cerebrovascular diseases.1 Consequently, more progress in reducing the mortality rate 
remains to be achieved. Reducing the mortality rate can be realized by lowering the 
incidence of cardiovascular disease, lowering the case-fatality rate of cardiovascular disease, 
or their combination.
In the recently released American Heart Association’s “Strategic Impact Goal Through 2020 
and Beyond,”2 the AHA charted a new course by focusing on improving cardiovascular 
health in addition to decreasing cardiovascular disease mortality. The AHA developed 7 
metrics that address cardiovascular health and created 3 states for each metric that reflected 
poor, intermediate, and ideal health. These metrics draw on the extensive body of 
epidemiological investigations that identified critical risk factors for cardiovascular disease 
and clinical trials that confirmed that lowering the level of some of these risk factors reduced 
the morbidity and mortality from cardiovascular disease. Furthermore, the AHA 2020 goals 
align more closely with the concept of primordial prevention3 and grew out of investigations 
that championed primordial prevention.4,5
Several studies have variably defined a low cardiovascular risk profile based on different 
risk factors and behaviors.6–10 However, at present, little is known about how well the new 
AHA 2020 goals predict the incidence and mortality from cardiovascular disease.11 
Therefore, the objective of the present study was to examine the relationship between the 
AHA 2020 goals and mortality from all causes and diseases of the circulatory system in a 
recent cohort of US adults.
Methods
We used the public data files for the 2006 follow-up of participants of the 1999 to 2000 and 
2001 to 2002 cycles of the National Health and Nutrition Examination Survey (NHANES). 
The samples in 1999 to 2000 and 2001 to 2002 were selected by use of a multistage, 
stratified sampling design and constitute representative samples of the noninstitutionalized 
civilian US population. Participants were interviewed at home and invited for a clinical 
examination. Details about the NHANES and its methods have been published.12 The study 
received approval from the National Center for Health Statistics Research Ethics Review 
Board, and participants were asked to sign an informed consent form.
The mortality status of participants ≥20 years of age through 2006 was determined from the 
National Death Index.13 Participants who were not deemed to have died as of December 31, 
2006, were considered to be alive. The International Classification of Diseases, 10th 
revision, codes I00 to I99 were used to identify deaths from diseases of the circulatory 
system.
The AHA 2020 goals include the following 7 behaviors and risk factors: smoking status, 
body mass index, physical activity, healthy dietary score, total cholesterol, blood pressure, 
and fasting plasma glucose.2 Participants who had smoked 100 cigarettes during their 
lifetime and were still currently smoking were defined as showing evidence of poor health. 
Former smokers who had quit within the previous 12 months were defined as showing 
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evidence of intermediate health. Former smokers who had quit for >12 months or 
participants who had never smoked were defined as showing evidence of ideal health. Body 
mass index was calculated from measured weight and height. Participants with a body mass 
index of ≥30, 25 to <30, and <25 kg/m2 had poor health, intermediate health, and ideal 
health, respectively. Participants were asked about the frequency and duration of 
participation in moderate and vigorous physical activity during the past 30 days. The weekly 
frequency of bouts of physical activity was calculated by multiplying the number of such 
bouts during the 30-day period by a factor of 7/30. For each participant, the weekly number 
of minutes of moderate activity (weekly frequency multiplied by the average duration for 
each bout) and the weekly number of minutes of vigorous activity (weekly frequency 
multiplied by the average duration for each bout multiplied by 2) were summed.14 Ideal 
health, intermediate health, and poor health were defined as ≥150, 1 to 149, and 0 minutes of 
moderate or vigorous activity per week, respectively.
In lieu of the AHA specific dietary criteria, we used the Healthy Eating Index (HEI) score as 
our healthy dietary score.15 The HEI includes 3 of the 5 primary criteria included in the 
AHA healthy dietary score: fruits and vegetables, whole grains, and sodium. Not included 
are sugar-sweetened beverages and fish consumption. Participants with an HEI score <50 
were assigned to poor health; those with a score of >50 to <81 were assigned to intermediate 
health; and those with a score of ≥81 were assigned to ideal health.16 The index was 
determined from dietary information collected by a single 24-hour recall administered in 
person to participants attending the medical examination.
Serum total cholesterol and high-density lipoprotein cholesterol were measured 
enzymatically on a Hitachi 717 Analyzer or a Hitachi 912 Analyzer (Roche Diagnostics, 
Indianapolis, IN). Ideal health, intermediate health, and poor health were defined as <200 
mg/dL, 200 to 239 mg/dL or treated to goal, and ≥240 mg/dL, respectively. Up to 4 attempts 
were made to measure blood pressure. The average of the last 2 measurements of blood 
pressure for participants who had 3 or 4 measurements, the last measurement for participants 
with only 2 measurements, and the only measurement for participants who had 1 
measurement were used. Current use of antihypertensive medications was based on self-
report. Ideal health, intermediate health, and poor health were defined as systolic blood 
pressure <120 mm Hg and diastolic blood pressure <80 mm Hg, systolic blood pressure of 
120 to 139 mm Hg and diastolic blood pressure of 80 to 89 mm Hg or treated to goal, and 
systolic blood pressure ≥140 mm Hg and diastolic blood pressure ≥90 mm Hg, respectively.
Although the AHA relied on fasting plasma glucose to determine hyperglycemia, we used 
hemoglobin A1c (HbA1c) concentrations for 2 reasons. First, recent (2010) recommendations 
from the American Diabetes Association allow the use of HbA1c to diagnose diabetes 
mellitus. Second, a sizeable percentage of participants in NHANES who have an 
examination are not fasting. Therefore, to maximize our sample size, we opted for 
concentration of HbA1c, which is not subject to fasting conditions. Participants with an 
HbA1c ≥6.5% had poor health; those with a concentration of 5.7 to <6.5% had intermediate 
health; and those with a concentration <5.7% had ideal health. Participants who reported 
being treated with insulin or oral medications to lower blood glucose and had a 
concentration <6.5% were deemed to have intermediate health.
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We included several covariates in our analyses: age, sex, race or ethnicity (white, black, 
Mexican American, other), educational status (less than high school, high school graduate/
General Educational Development or equivalent, more than school), alcohol use, self-
reported health status, health insurance, history of cardiovascular disease, and history of 
cancer. We calculated alcohol use from several questions regarding the use of alcohol during 
a participant’s lifetime and 12-month period and recent use. Men who consumed an average 
of ≤2 drinks per day and women who consumed on average ≤1 drink per day were 
considered moderate drinkers, and men who consumed an average of >2 drinks per day and 
women who consumed on average >1 drink per day were considered excessive drinkers. 
Self-reported health status was determined from the question, “Would you say your health in 
general is excellent, very good, good, fair, or poor?” Health insurance coverage (yes/no) was 
derived from the question, “Are you covered by health insurance or some other kind of 
healthcare plan?” Participants who reported ever being told by a doctor or other health 
professional that they had congestive heart failure, coronary heart disease, angina pectoris, 
heart attack, or stroke were considered to have a history of cardiovascular disease.
Our analyses were limited to participants who were ≥20 years of age. We calculated 
mortality rates per 1000 person-years of follow-up. Adjustment for age or age and sex was 
performed by use of the direct method with the year 2000 US population. Differences in 
age-and sex-adjusted proportions were examined with t tests. Pearson correlations adjusted 
for age and sex between the ranks of continuous variables used to formulate the health 
metrics were calculated. Risk estimates for mortality were calculated by the use of Cox 
proportional hazards regression analysis for the individual and number of 2020 
cardiovascular health goals. In these analyses, we adjusted for age (continuous), sex, race or 
ethnicity (white, black, Mexican American, other), educational attainment (less than high 
school, high school graduate or equivalent, and beyond high school), alcohol use (excessive 
alcohol use yes/no), self-reported health status (fair or poor health; good, very good, or 
excellent health), health insurance coverage (yes/no), and histories of cardiovascular disease 
(yes/no) and cancer (yes/no). Proportionality assumptions were examined with Schoenfeld 
residuals and were found to be met. Estimates were calculated with SAS and SUDAAN, the 
latter to account for the complex sampling design of the survey.
Results
Of the 9471 participants ≥20 years of age who had an examination, 10 were ineligible for 
the follow-up study and 8005 had sufficient information for the cardiovascular health 
metrics. Additional exclusions for incomplete information of other study variables reduced 
the sample size to 7622. The sample included 3635 men, 3987 women, 3857 whites, 1329 
blacks, 1814 Mexican Americans, and 622 of another race or ethnicity. The median age was 
43 years.
The age- and sex-adjusted prevalence of ideal health for the individual health factors ranged 
from 10.9% for the HEI dietary score to 81.3% for HbA1c (Table 1). Without adjustment, 
1.5% of participants had no ideal health criteria, 8.4% had 1, 19.9% had 2, 27.4% had 3, 
22.1% had 4, 14.0% had 5, 5.5% had 6, and 1.1% had 7 (after adjustment for age and sex: 
1.5%, 8.6%, 20.3%, 27.5%, 21.9%, 13.8%, 5.4%, and 1.0%, respectively). The 
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interrelationships between the dichotomized health metrics and correlations for continuous 
variables are shown in Tables 2 and 3.
During a median follow-up of 5.8 years, 532 deaths (186 deaths resulting from diseases of 
the circulatory system) were recorded among the 7622 participants. Smoking status, dietary 
score, HbA1c, physical activity, and blood pressure were significantly associated with all-
cause mortality (Table 4). In the maximally adjusted model, only smoking status, physical 
activity, HEI score, blood pressure, and HbA1c retained their statistical significance. Five 
metrics (smoking status, physical activity, HEI score, blood pressure, and HbA1c) showed 
evidence of a graded response, indicating that the intermediate health categories for these 
metrics were associated with reduced all-cause mortality. With the exception of blood 
pressure, the hazard ratios for mortality from diseases of the circulatory system generally 
were aligned with those for all-cause mortality, although the confidence limits included 
unity.
Four of the 7 dichotomized cardiovascular health metrics (ideal health versus intermediate 
or poor) were significantly associated with all-cause mortality (the Figure, A). Ranked 
according to the magnitude of the hazard ratio for all-cause mortality were ideal smoking 
status, HbA1c and dietary score, and physical activity. For mortality from diseases of the 
circulatory system, ideal health for blood pressure proved to be a particularly strong 
determinant. Furthermore, dietary score and HbA1c were also significantly associated with 
this outcome. We also redid the above models after revising the outcome variable by 
comparing ideal and intermediate health with poor health (the Figure, B). The resulting 
magnitude and rank order of the hazard ratios showed some differences from those of the 
models in part A of the Figure.
When the dichotomized cardiovascular health metrics were summed, a strong inverse 
relationship was present between the number of ideal health metrics and mortality from all 
causes or diseases of the circulatory system (Table 5). Because so few deaths occurred 
among participants with 6 or 7 ideal health metrics, we grouped participants with 5, 6, or 7 
ideal health metrics into 1 category. Compared with participants with no ideal health 
metrics, those with ≥5 had reduced all-cause mortality (adjusted hazard ratio, 0.22; 95% 
confidence interval [CI], 0.10–0.50) and mortality from diseases of the circulatory system 
(adjusted hazard ratio, 0.12; 95% CI, 0.03–0.57). When participants who died during the 
first year of follow-up were excluded from the analyses (481 deaths, 7571 at risk), a strong 
reduction in risk with increasing number of ideal health metrics remained evident (adjusted 
hazard ratios for participants with 1, 2, 3, 4, and ≥5 ideal health metrics are 0.68 [95% CI, 
0.32–1.45], 0.69 [95% CI, 0.31–1.52], 0.58 [95% CI, 0.24–1.38], 0.49 [95% CI, 0.19–1.27], 
and 0.22 [95% CI, 0.08–0.62]). Furthermore, after the exclusion of participants with self-
reported cardiovascular disease from the analyses, the hazard ratios for participants with ≥5 
ideal health metrics were similar to the hazard ratios for the entire analytic sample of 7622 
participants.
We also created a score out of the 7 cardiovascular health metrics ranging from 0 to 14 by 
assigning a value of 0 for poor health, 1 for intermediate health, and 2 for ideal health for 
each metric. The maximally adjusted hazard ratio per unit score was 0.86 (95% CI, 0.81–
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0.91) for all-cause mortality and 0.83 (95% CI, 0.76–0.91) for mortality resulting from 
diseases of the circulatory system.
Discussion
Using a recent national sample of US adults, we show that the number of ideal 
cardiovascular health metrics was strongly and inversely related to mortality from all causes 
and diseases of the circulatory system. These data, which are consistent with the results from 
a recent prospective study,11 suggest that attainment of the AHA 2020 goals could result in 
substantial reductions in mortality.
Since the 1960s, mortality from coronary heart disease has enjoyed a more or less sustained 
decrease.17 The early period of this drop was likely governed primarily by reductions in the 
prevalence of smoking,18 mean concentration of total cholesterol,19 and blood pressure.20 
The introduction of the coronary care unit during the 1960s and its subsequent expansion 
also saved lives. The development of ever more sophisticated medical and surgical 
treatments in ensuing decades contributed further to reducing the mortality rate from 
coronary heart disease. Between 1980 and 2000, treatments accounted for ≈47% and 
reductions in risk factors for ≈44% of the deaths from coronary heart disease that were 
prevented or postponed in the United States.21 Models consistently show that enormous 
reductions in the mortality from coronary heart disease are achievable with meaningful 
reductions in risk factors.22 Thus, the development of the AHA 2020 goals that emphasize 
cardiovascular health represents an important evolution from disease management to health 
promotion.
Controlling for confounding constitutes a major challenge in observational studies. To 
examine the impact of various possible confounders on our risk estimates, we presented 
several proportional hazards models that contained different sets of covariates. We included 
self-reported health and prevalent chronic disease as possible confounders because these 
factors are related to mortality and to the AHA cardiovascular health metrics. Conceivably, 
these factors could also form part of the causal pathways between the AHA metrics and 
mortality, in which case the model was overadjusted and the benefits attributable to the 
metrics were underestimated. However, a comparison of models with and without these 
factors shows that self-reported health and prevalent chronic disease did not materially 
affect the hazard ratios. Similar considerations apply to the model that adds all the AHA 
metrics.
Our analyses using the NHANES 1999 to 2002 data show that only a small percentage of 
US adults met ideal criteria for all 7 cardiovascular health metrics, a result that is 
disappointing but perhaps not surprising. One consequence of the very small percentage of 
participants in the extremes of the distribution is that large cohorts with large numbers of 
deaths are needed to form stable and accurate estimates of the risk for mortality among those 
with 6 or 7 ideal health metrics. Most adults met 2, 3, or 4 ideal health metrics, all of which 
are associated with a substantial reduction in mortality compared with participants with no 
ideal health metric. The challenge for clinical and public health professionals is to keep 
moving the distribution of the number of health metrics in the desired direction. In this 
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regard, a number of major efforts are underway. An example of a clinical program is the 
AHA’s The Guideline Advantage, jointly managed by the American Cancer Society, 
American Diabetes Association, and AHA.23 An example of a recent major public health 
initiative launched by the US Department of Health and Human Services is the Communities 
Putting Prevention to Work initiative, which funded 50 communities with the goal of 
reducing tobacco use, increasing physical activity, improving nutrition, and reducing 
obesity.24 In addition to continued efforts to promote healthy lifestyles, public health 
programs have put a greater focus on systems and environmental changes to effect changes 
and options for healthy lifestyle choices.25–28 Examples of such policy and systems level 
efforts include smoking bans and restrictions in public places29,30 and recent efforts to 
address the amount of sodium in foods.31,32
In the AHA statement, the prevalence of an ideal healthy dietary score was <0.5%. In 
contrast, our use of the HEI score and the cut points we chose yielded a prevalence of an 
ideal healthy dietary score of ≈11%. How well the AHA’s healthy dietary score predicts 
mortality remains unknown. However, 3 of its 5 primary components are shared with the 
HEI score.
Five of the 7 metrics (current smoking, physical activity, healthy diet score, blood pressure, 
and HbA1c) showed a gradient in risk, suggesting that health gains are feasible when adults 
move from poor to intermediate health and when they move from intermediate to ideal 
health for most health metrics. Future studies comparing the gain in health benefits 
associated with a change from poor to intermediate health with the gain associated with a 
change from intermediate to ideal health for each metric may yield helpful insights that will 
be of value to clinicians in optimizing the cardiovascular health of their patients.
Not all of the individual metrics contributed to the reduction in risk; body mass index and 
total cholesterol status were not significantly related to mortality from all causes. The 
reasons for these findings are not clear. Of note, a previous analysis of the mortality 
experience by NHANES III participants found a weak relationship between body mass 
index and all-cause mortality.33 The authors of that study postulated that treatment for some 
of downstream effects of obesity such as dyslipidemia and hypertension may have blunted 
some of the risk associated with being obese. In addition, follow-up time may not have been 
long enough to discern the effects of body mass index. An earlier study among men 
observed no associations for body mass index or other measures of adiposity with coronary 
heart disease mortality during up to 14 years of follow-up but found positive associations 
after 14 years of follow-up,34 suggesting that the effects of adiposity may not become 
apparent for some time. A recent meta-analysis found that anthropometric measures such as 
body mass index did not improve risk prediction for cardiovascular disease once traditional 
cardiovascular risk factors were considered.35 From a public health perspective, the 
prevention and control of excess weight represents a valuable public health goal because, in 
addition to other considerations, excess weight causes dyslipidemia, high blood pressure, 
and hyperglycemia.
Hypercholesterolemia is considered 1 of the 3 cardinal risk factors for coronary heart disease 
and has been shown to be a risk factor for all-cause mortality.36 Consequently, the poor 
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prediction by this risk factor in the present study was unexpected. The use of cholesterol-
lowering medications, particularly in the form of statins, has been increasing rapidly in the 
United States,37 and some of the non–cholesterol-lowering effects of statin use may have 
played a role in our findings. Furthermore, the use of cholesterol-lowering medications 
among the participants with untreated hypercholesterolemia at baseline likely increased, 
which may have negated some of the adverse effects suggested by elevated baseline 
concentrations. Alternatively, the lack of a significant association may have represented a 
chance occurrence. It is also possible that a significant association may emerge with longer 
follow-up of the cohort.
Our results should be considered in light of several limitations. First, the follow-up of our 
cohort was of limited duration. Consequently, the number of deaths, even at >500, posed a 
major challenge in estimating the risks in the extremes of the distribution of the number of 
ideal health metrics. Thus, collapsing some categories for some analyses was necessary. 
Furthermore, the limited number of deaths also led us not to undertake stratified analyses by 
various demographic or other factors. Second, we had only a single measurement for all the 
health metrics; thus, were unable to account for changes in these metrics that may have 
occurred during the course of the follow-up period. Finally, as noted before, we did not 
adhere perfectly to all of the AHA 2020 health metrics for practical reasons.
Other studies are needed to examine the relationships between the AHA 2020 goals and the 
incidence and mortality of cardiovascular disease. Examining these relationships in 
historical and in more current cohorts will provide important feedback about the choice of 
metrics and the selected definitions for poor, intermediate, and ideal health.
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In 2010, the American Heart Association presented a set of 7 metrics that were designed 
to promote cardiovascular health: smoking status, body mass index, physical activity, 
healthy dietary score, total cholesterol, blood pressure, and fasting plasma glucose. For 
each metric, 3 levels of health were defined (poor, intermediate, and ideal health). The 
state of ideal health for each metric emphasizes the concept of primordial prevention. 
Using data from a nationally representative cohort of US adults, we found that about half 
of adults had 3 or 4 ideal health metrics (only ≈1% met the ideal health criteria for all 7 
metrics). Furthermore, we observed a strong dose-response relationship between the 
number of ideal health metrics and mortality from all causes and diseases of the 
circulatory system. Clinicians can reduce cardiovascular morbidity and mortality in their 
patient populations not only by helping their patients maximize the number of attained 
ideal cardiovascular health metrics but also by helping patients with poor health for some 
metrics transition to intermediate health. Optimizing cardiovascular health involves 
addressing key lifestyle behaviors of smoking, diet, and physical activity. Besides the 
resources in their practices, clinicians can opt to draw on available institutional, clinical, 
and community resources. An implication of the AHA goals and our findings is that the 
cardiovascular health of patients should be monitored from an early age. Clinicians 
should strive to maximize the numbers of patients with hypercholesterolemia, 
hypertension, and hyperglycemia who require pharmacological management who are on 
treatment and under control.
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Adjusted hazard ratios (95% confidence intervals) for mortality from all causes and diseases 
of the circulatory system among 7622 participants ≥20 years of age, National Health and 
Nutrition Examination Survey, 1999 to 2002. The National Death Index was used to 
ascertain mortality through 2006. A, Hazard ratios for ideal vs intermediate and poor health 
for each cardiovascular health metric. B, Hazard ratios for ideal and intermediate health vs 
poor health for each cardiovascular health metric. Hb indicates hemoglobin.
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Table 1
Selected Age- and Sex-Adjusted Baseline Characteristics Among Adults ≥20 Years of Age by Mortality 
Status, National Health and Nutrition Examination Survey 1999 to 2002
Characteristics Deceased (n=532) Survivors (n=7090)
Age, y* 67.0 (64.7– 69.3) 44.2 (43.5–44.9)
Men, %† 66.5 (54.2–76.8) 47.7 (46.6–48.9)
Whites, % 57.8 (50.7–64.5) 73.3 (69.5–76.8)
Education beyond high school, % 34.2 (25.1–44.5) 54.3 (51.3–57.3)
Excessive alcohol use, % 8.7 (5.6–13.3) 12.7 (9.6–6.7)
Poor or fair health, % 44.7 (34.8–55.1) 14.4 (12.8–16.3)
Has health insurance, % 83.7 (70.4–91.7) 82.8 (80.9–84.5)
History of cardiovascular disease, % 34.0 (24.5–45.0) 7.1 (6.3–7.9)
History of cancer, % 13.4 (9.8–17.9) 7.2 (6.4–8.1)
Body mass index, kg/m2 30.1 (28.2–31.9) 28.0 (27.7–28.3)
Physically active, min/wk‡ 7.3 (3.9–13.0) 33.2 (27.7–39.7)
Healthy Eating Index score, % 58.7 (56.2–61.3) 63.9 (63.1–64.7)
Total cholesterol, mg/dL 204.8 (192.2–217.4) 203.5 (201.6–205.4)
Systolic blood pressure, mm Hg 122.5 (119.4–125.5) 122.6 (121.9–123.4)
Diastolic blood pressure, mm Hg 70.2 (68.0–72.5) 72.5 (71.9–73.1)
Hemoglobin A1c, % 5.8 (5.5–6.1) 5.4 (5.4–5.5)
Not currently smoking, % 68.6 (55.3–79.4) 73.2 (70.7–75.5)
Body mass index <25 kg/m2, % 27.4 (18.5–38.6) 34.8 (33.1–36.6)
Physically active, % 27.0 (18.7–37.3) 42.6 (39.6–45.7)
Healthy Eating Index ≥80, % 4.3 (2.5–7.3) 11.2 (9.6–13.1)
Total cholesterol <200 mg/dL, % 42.9 (36.5–49.5) 45.1 (43.4–46.7)
Optimal blood pressure, % 36.4 (28.9–44.6) 40.7 (38.6–42.9)
Hemoglobin A1c <5.7%, % 66.0 (55.4–75.1) 82.0 (79.9–83.9)
No. of AHA 2020 metrics for ideal health
 0 4.7 (1.6–12.8) 1.5 (1.1–1.9)
 1 9.6 (6.3–14.3) 8.4 (7.3–9.7)
 2 28.6 (21.4–37.1) 19.9 (18.5–21.4)
 3 28.0 (20.2–37.4) 27.6 (26.0–29.2)
 4 24.0 (16.0–34.4) 22.1 (20.9–23.4)
 ≥5 5.2 (1.7–14.6) 20.5 (18.5–22.8)






Means represent back-transformed means of Box-Cox transformation.
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